[QEBR] is Jumping into the Lucrative Sports Beverage Space with a New Acquisition!

[Image](?awt_a=1jS4A&awt_l=Dx3Vy&awt_m=fxoYlJaFzQvde4A) [Image]( Virtual Medical International Inc. (OTC: QEBR) May be the Next Wellness Green Stock to Hit the Spotlight on Wall Street! More and more consumers are opting to take better care of their health these days and many are now trying to shed their pandemic weight gains. One huge market gaining momentum is the sports beverage market as these drinks can help to boost energy and endurance and even help to burn fat and aid in workout recovery. Virtual Medical International Inc. (OTC: QEBR) has announced recently that it is buying Gen X Fitness Water! Gen X Fitness Water is free of all doping substances and is lightly sweetened with natural stevia syrup and grape flavoring. There are no added sugars, carbohydrates, or proteins and therefore no added calories. According to Absolute Market Insights, the global sports drink market is expected to hit $32.83B by 2027, growing at an estimated CAGR of 4.7% as the drinks gain popularity with athletes and a growing consumer awareness on health are boosting the demand for them. QEBR is also tackling the monstrous CBD market with several endeavors that could get it noticed around the world. As this small cap company gains ground in the wellness arena and the sports beverage space, current levels could be soon heading skyward! Find out why QEBR could be poised for substantial upside ahead at current levels! Our Exclusive Report On: [Image]( Green leaf stocks have been soaring higher in recent months, led by optimism that President-elect Joe Biden and the Senate could finally legalize the plant and leave prohibition in the past. QEBR is a low-priced stock that may see tremendous upside as the company only recently decided to return to its medical roots by entering a multi-billion-dollar space. This could be a ground-floor situation unfolding! [Image]( QEBR is aiming to capitalize on the important medical needs of millions of adults across the globe who could benefit from natural wellness products such as CBD. CBD is being hailed by many as the greatest thing since sliced bread! As research keeps revealing more therapeutic benefits of this marijuana cannabinoid for the mind and body, the CBD train isn't about to slow down anytime soon. In fact it is expected to speed up and QEBR is jumping onto the train with some big developments! Hurry and add the stock to your watch list! Shares were as high as 55 cents earlier this month and as high as 90 cents in December! When some people hear “CBD,” their minds automatically think marijuana. And while there is a connection, it’s not as close as one might think. [Image]( Since recreational and medical cannabis is available in several states now, it’s important to note the differences. CBD is primarily a hemp derivative, which is like a cousin to marijuana. It's not the same plant. A major positive has happened for the hemp and CBD industry because of coronavirus. The industry has been seeing stellar growth this year as more consumers turn to CBD during the pandemic. Nearly 40% of 5,000 CBD consumers surveyed in June by Brightfield said they've increased their consumption. At least 20% of consumers are using more CBD products as a direct result of COVID, according to a June study by Chicago-based Aclara Research, a firm that analyzes cannabis and CBD consumers and works in collaboration with Nielsen Global Connect. CBD's popularity has skyrocketed in 2020 but it had already been seeing stellar growth in recent years. What started as a niche alternative health treatment has become a nationwide craze. CBD is not just in oils and tinctures anymore. It is being infused into all kinds of products, including lattes, alcohol, makeup, bedsheets, bath bombs, and even dog treats. FarmShare, a North Carolina hemp farm and processing facility is the very first acquisition for the company following QEBR's transition to the exciting and lucrative CBD sector. [Image]( The farm had proudly grew tobacco for three generations and today hemp offers an exciting new future… FarmShare manages a 50-acre farm in La Grange, North Carolina, which it is transitioning from tobacco to industrial hemp;and a 5,000 square foot processing facility with 50-gallon/daily capacity. In the 2020 season, FarmShare harvested 50 acres of hemp and manufactured 258 gallons of CBD oil under the brand name FarmShare QD. Currently, management expects to plant 75 acres of industrial hemp and produce 400 gallons of CBD oil for the 2021 season!! "FarmShare's high quality full spectrum distillate, presented as FarmShare QD brand, is a great brand to bring under the 'Amsterdam café' banner. This facility gives us an immediate presence in the southeast U.S. market, as well as the ability to increase capacity with existing assets as we move forward with our planned expansion strategy," said QEBR CEO Larson Elmore. "The FarmShares contracted hemp farm production model is producing positive results where many other farm operations are struggling to break even.This is credited to our focus on partnering with the right farm and extraction operations and identifying the hemp varietals that will perform the best in the soil and climate conditions that we have identified as essential to maximizing hemp production," stated Blair Merriam, the Managing Director of FarmShares. Through QEBR's wholly-owned subsidiary, the company has also established the brand name "Amsterdam Café: Welcome to Your Whole Health™. [Image](?awt_a=1jS4A&awt_l=Dx3Vy&awt_m=fxoYlJaFzQvde4A) This is the company's first steps to becoming a comprehensive, vertically integrated organization within the CBD sector! The diversified, multi-channel business model derives revenue from product sales through company-owned retail stores, franchise stores, domestic and international franchise activities, third party contract manufacturing, e-commerce and corporate alignments. The company's business model is designed to help consumers improve the health and quality of their lives by making available an array of high quality, CBD-centric products consistent with a healthy lifestyle. QEBR has plans to acquire and open CDB Stores all across the U.S.A. and Europe! People are using CBD for almost everything now. Name a medical condition and there’s likely someone out there treating it with this cannabinoid. According to Single Care, of the Americans who use CBD, the most common uses are for pain relief (64%), anxiety (49%), and insomnia (42%). According to a 2019 Gallup poll, 64% of Americans are familiar with CBD and/or products infused with it. The awareness of it is growing as the years go by. The CBD boom in 2019 came on the heels of the December 2018 passage of the Agriculture Improvement Act, better known as the 2018 Farm Bill. This legislation removed the low-THC hemp and its derivatives from the Controlled Substances Act. Hemp-derived CBD products are now legal in all 50 states, as long as they contain no more than 0.3% THC according to the Food and Drug Administration. By 2023, the European CBD market is estimated to reach €1.4 billion! Germany and the UK lead the European CBD market, followed by Switzerland, Austria, Spain, and Greece. It was at the end of last year that the UN Commission on Narcotic Drugs (CND) reclassified cannabis and it is no longer considered a risky narcotic! After reviewing recommendations from the World Health Organization (WHO) on marijuana and its derivatives, the UN had a historic vote of 27 in favour, 25 against, and one abstention on removing the drug from Schedule IV of the 1961 Single Convention on Narcotic Drugs — where it was listed alongside deadly, addictive opioids, including heroin. The CND has now recognized the medicinal and therapeutic potential of the plant! This could send a shock wave through Europe as countries look to global conventions for guidance, and United Nations' recognition is a symbolic win for marijuana advocates. QEBR had a big announcement last month, revealing that it has entered into an agreement to purchase Gen X Fitness Water, a next generation sports beverage created to help athletes maximize their workouts. [Image](?awt_a=1jS4A&awt_l=Dx3Vy&awt_m=fxoYlJaFzQvde4A) Gen X Fitness Water is formulated with L-Carnitine Tartrate, a combination of carnitine and tartaric acid. Carnitine is a naturally occurring amino acid structure that helps keep the body's cells powered and working efficiently. Found in nearly all cells of the body, L-carnitine's primary function is breaking down fatty acids, converting them to energy. It also aids in the removal of waste products from the cells, preventing them from accumulating and causing muscle fatigue. The drink comes in 500 ml individual, ready to drink servings. Each serving contains 1,000 mg of Gen X's proprietary L-Carnitine Tartrate formulation to facilitate absorption and help boost energy and endurance, the burning of body fat for energy, increasing resistance and aiding in recovery. Gen X Fitness Water is free of all doping substances and is lightly sweetened with natural stevia syrup and grape flavoring. Consumers are wanting to be healthier and with COVID-19, many opted to get fit while in lock down and many now are looking to drop their pandemic weight gain. According to Absolute Market Insights, the global sports drink market is expected to hit $32.83B by 2027, growing at an estimated CAGR of 4.7% as the drinks gain popularity with athletes and a growing consumer awareness on health are boosting the demand for them. Larson Elmore, QEBR CEO noted that "Gen X Fitness Water provides pure hydration during physical activity making it popular with bodybuilders and other endurance athletes as part of their pre-workout regimen. Equally important, there are no added sugars, carbohydrates, or proteins and therefore no added calories." In showing why this acquisition fits into Virtual Medical's business expansion model, Mr. Elmore explained that "Gen X Fitness Water is a great product for Amsterdam Café and our mission to support general health and wellness. We believe it will be well received by distributors and customers across our planned network. Going forward we expect to expand the line to include other flavors as well as a CBD-infused version." QEBR may have bottomed out around these levels so start your research quickly! QEBR could see a big bounce ahead as the company re-focuses onto the multi-billion-dollar wellness green leaf space! EMAIL}/redirect GENERAL NOTICE AND DISCLAIMER - PLEASE READ CAREFULLY THE FOLLOWING NOTICE AND DISCLAIMER MUST BE READ AND UNDERSTOOD AND YOU MUST AGREE TO THE TERMS CONTAINED THEREIN BEFORE USING THIS WEBSITE OR SUBSCRIBING TO OUR NEWSLETTER. We are engaged in the business of advertising and promoting companies. All content on our website is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities. Neither the owner of DearWallstreet.com nor any of its members, officers, directors, contractors or employees are licensed broker-dealers, account representatives, market makers, investment bankers, investment advisers, analyst or underwriters. Investing in securities, including the securities of those companies profiled or discussed on this website is for individuals tolerant of high risks. Viewers should always consult with a licensed securities professional before purchasing or selling any securities of companies profiled or discussed on DearWallstreet.com. It is possible that a viewer's entire investment may be lost or impaired due to the speculative nature of the companies profiled. Remember, never invest in any security of a company profiled or discussed on this website unless you can afford to lose your entire investment. Also, investing in micro-cap securities is highly speculative and carries an extremely high degree of risk. DearWallstreet.com makes no recommendation that the securities of the companies profiled or discussed on this website should be purchased, sold or held by viewers that learn of the profiled companies through our website. DearWallstreet.com has been retained by an unrelated third party to perform promotional and advertising services for a limited time with respect to the company we are profiling or discussing on this website and in exchange for such services has received cash compensation from such third party. Questions regarding this website may be sent to info@DearWallstreet.com. Some of the content on this website contains forward-looking information within the meaning of Section 27A of the Securities Act of 1993 and Section 21E of the Securities Exchange Act of 1934 including statements regarding expected continual growth of a company and the value of its securities. In accordance with the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 it is hereby noted that statements contained herein that look forward in time which include everything other than historical information, involve risk and uncertainties that may affect a company's actual results of operation. A company's actual performance could greatly differ from those described in any forward looking statements or announcements mentioned on this website or the websites contained within. Factors that should be considered that could cause actual results to differ include: the size and growth of the market for the company's products; the company's ability to fund its capital requirements in the near term and in the long term; pricing pressures; unforeseen and/or unexpected circumstances in happenings; etc. and the risk factors and other factors set forth in the company's filings with the Securities and Exchange Commission. However, a company's past performance does not guarantee future results. Generally, the information regarding a company profiled or discussed on this website is provided from public sources. DearWallstreet.com makes no representations, warranties or guarantees as to the accuracy or completeness of the information provided or discussed. Viewers should not rely solely on the information obtained through our website or in communications originating from our website. Viewers should use the information provided by us regarding the profiled companies as a starting point for additional independent research on the companies profiled or discussed in order to allow the viewer to form his or her own opinion regarding investing in the securities of such companies. Factual statements, or the similar, made by the profiled companies are made as of the date stated and are subject to change without notice and DearWallstreet.com has no obligation to update any of the information provided. DearWallstreet.com, its owners, officers, directors, contractors and employees are not responsible for errors and omissions. From time to time certain content on this website is written and published by our employees or third parties. In addition to information about our profiled companies, from time to time, our website will contain the symbols of companies and/or news feeds about companies that are not being profiled by us but are merely illustrative of certain activity in the micro cap or penny stock market that we are highlighting. Viewers are advised that all analysis reports and news feeds are issued solely for informational purposes. Any opinions expressed are subject to change without notice. It is also possible that one or more of the companies discussed or profiled on this website may not have approved certain or any statements within the website. DearWallstreet.com encourages viewers to supplement the information obtained from this website with independent research and other professional advice. The content on this website is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Third Party Web Sites and Other Information This website may provide hyperlinks to third party websites or access to third party content. DearWallstreet.com, its owners, officers, directors, contractors and employees are not responsible for errors and omissions nor does DearWallstreet.com control, endorse, or guarantee any content found in such sites. DearWallstreet.com does not control, endorse, or guarantee content found in such sites. By accessing, viewing, or using the website or communications originating from the website, you agree that DearWallstreet.com, its owners, officers, directors, contractors and employees, are not responsible for any content, associated links, resources, or services associated with a third party website. You further agree that DearWallstreet.com, its owners, officers, directors, contractors and employees shall not be liable for any loss or damage of any sort associated with your use of third party content. Links and access to these sites are provided for your convenience only. DearWallstreet.com uses third parties to disseminate information to subscribers. Although we take precautions to prevent others from obtaining our subscriber list, there is a risk that our subscriber list, through no wrong doing on our part, could end up in the hands of an unauthorized party and that subscribers will receive communications from unauthorized third parties. We encourage viewers to invest carefully and read the investor issuer information available at the web sites of the United States Securities and Exchange Commission (SEC). The SEC has launched an investor-focused website to help you invest wisely and avoid fraud at www.investor.gov and filings made by public companies can be viewed at www.sec.gov and/or the Financial Industry Regulatory Authority (FINRA) at: www.finra.org. In addition, FINRA has published information at its website on how to invest carefully at www.finra.org/Investors/index.htm. Income Disclaimer: Testimonials and examples used here are exceptional results which may not apply to the average purchaser. They are not intended to represent or guarantee that anyone will achieve the same or similar results through our service. The use of our information should be based on your own due diligence, and you agree that our company is not liable for any success or failure of your business that is directly or indirectly related to the use of our information. As with any business, your results may vary, and will be based on your individual capacity, business experience and expertise. There are no guarantees concerning the level of success you may experience. Income statements made by our customers are only estimates of what they have earned; there is no guarantee that you will make these levels of income. When using our information you accept the risk that these earnings and income statements differ by individual. There is no assurance that examples of past earnings can be duplicated in the future. There are unknown risks in business and on the internet that we cannot anticipate which can reduce results. We therefore cannot guarantee your future results or success, and are not responsible for your actions. DearWallstreet.com has been paid up to $400,000 in cash compensation from CZA for this profile of Virtual Medical International, Inc. (OTC: QEBR) which services include the issuance of this release and other opinions that we release concerning Virtual Medical International, Inc. (OTC: QEBR). DearWallstreet.com has not investigated the background of CZA., the hiring party, or Virtual Medical International, Inc. (OTC: QEBR). Anyone viewing this newsletter should assume CZA. or affiliates of CZA., own shares of Virtual Medical International, Inc. (OTC: QEBR) which they plan to liquidate, and further understand that the liquidation of those shares may or may not negatively impact the share price. DearWallstreet.com has received this amount as a production budget for advertising efforts and will retain amounts over and above the cost of production, copywriting services, mailing and other distribution expenses as a fee for our services. As such, our opinion is neither unbiased nor independent, and you should consider that when evaluating our statements regarding Virtual Medical International, Inc. (OTC: QEBR). Rua Frei Tomé de Jesus n. 18 1 dto. Lisboa Lisboa 1700-215 PORTUGAL [Unsubscribe]( [Change subscriber options](